Background: There is strong evidence supporting the use of aspirin for secondary prevention of cardiovascular (CV) events such as myocardial infarction (MI) or stroke. However, more recent significant evidence shows the risk of major extracranial or gastrointestinal bleeds counterbalances any benefit in primary prevention. We assessed inappropriate aspirin use by over 65-year-olds admitted to a rehabilitation hospital. Methods: We recorded admission demographics, aspirin use, anti-coagulant use, previous MI or stroke and other CV risk factors on an anonymous, 'opt-in' basis, over a prospective thirty-day period. We interviewed patients, reviewed medication documentation and phoned GPs.
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Aspirin use was defined as appropriate for patients with previous MI, stroke, stent or at high risk (i.e. having a 10-year CV mortality risk > 10% or two risk factors from: hypertension, hyperlipidaemia, atrial-fibrillation, diabetes, smoker, unstable-angina) Results: There were 55 over 65-year-old admissions, 35 female(F), 20 male(M) with an average age of 81. 56% (17 F, 14 M) were taking aspirin. 36% (10 F, 1 M) of these were taking aspirin inappropriately. The majority of patients did not know why they had been prescribed aspirin. Some had been taking aspirin for over twenty years. One patient had a previous perforated gastric ulcer and one suffered regular nose bleeds. We discussed the risks and benefits of aspirin.~73% taking it inappropriately did not want to change their medication routine.
The 36% rate of inappropriate use in our over-65 group compares with 19% in two Irish 2013 assessments of 619 all-age patients taking aspirin in the community. Conclusions: More than a third of over-65s admitted for rehabilitation taking aspirin were using it inappropriately, increasing potentially fatal bleeding risks and achieving no mortality benefit. In light of this, a new algorithm for aspirin use, based on evidence and guidelines, was developed by the medical team to help rationalise medications and improve outcomes.
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